<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-MWT6JAF7</identifier><date>2017</date><creator>Matsui, Yusuke</creator><relation>documents/doc/M/URN_NBN_SI_doc-MWT6JAF7_001.pdf</relation><relation>documents/doc/M/URN_NBN_SI_doc-MWT6JAF7_001.txt</relation><format format_type="issue">4</format><format format_type="volume">51</format><format format_type="type">article</format><format format_type="extent">str. 393-400, II</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">300515328</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-MWT6JAF7</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">hepatocelularni karcinom</subject><subject language_type_id="slv">Lipiodol</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">zdravljenje</subject><title>Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma</title><title>identification of a threshold value predicting tumor recurrence</title></Record>